USD Revenue Stabilization on Watch as OEM Headwinds Persist
After Q1's shock from European OEM cutbacks, KPIT guidance promises steadier topline in Q2. The Street waits on proof that margins recover and order execution holds as the stock trades 72% below its all-time high.
What to Expect
~₹1,675 Cr
On-plan with July 1 guidance that Q2 will be 'similar range' to Q1. Implies flat YoY in USD, modest INR strength tailwind.
₹120–₹135 Cr (est.)
Q1 saw ₹116 Cr (down 32% YoY). Recovery hinges on margin stabilization despite OEM volume headwinds.
~20–21%
Management target is 21%; Q1 compression from OEM actions raises execution risk. Watch for commentary on cost/ramp.
USD 257M
Q1 secured healthy order TCV including small Indian OEM win. Q2 TCV size and mix will signal demand trajectory.
A strong quarter would show revenue stabilization at or slightly above Q1 levels (in USD), with margins recovering toward 21%+ EBITDA, and commentary that European OEM client pressures are easing. A weak quarter would be if revenue falls below Q1 guidance, margins remain compressed below 20%, or management signals further client headwinds into H2.
On Track for Full-Year?
KPIT's trajectory remains uncertain. Q1 FY27 saw rupee revenue growth of 8.9% YoY (₹1,674.99 Cr vs ₹1,538.76 Cr in Q1 FY26) but a 1% YoY decline in USD terms due to sudden European OEM client actions. Management's July 1 guidance that Q2 will be 'similar range' to Q1 signals stabilization after the shock, not a rebound. Profit, however, fell 32% YoY in Q1 (₹116 Cr vs ₹171 Cr), a steeper decline than topline suggests margin compression under client pressure. For Q2 to be 'on track,' the Street expects proof that margins recover on the stable revenue base, and that the small Indian OEM win—plus the backlog of recent TCV deals (₹257M in Q1)—offset further Western attrition. Full-year guidance remains unverified against actuals; the result will clarify H2 momentum.
What the Street Says
Since Last Quarter
Corporate Actions & Governance: KPIT reconstituted its Nomination & Remuneration Committee (Aug 26) and appointed Dr. Nirmala Pandit as Non-Independent Non-Executive Director (Jul 29). The company completed voluntary liquidation of Somit Solutions Inc. (Somit USA), its US step-down subsidiary (Jul 14). Regulatory: KPIT incurred a ₹1.23 Cr penalty from the Collector of Stamps for a 4-day delay in lodging an NCLT order post-Caresoft acquisition (Aug 27)—routine compliance matter. Capital & Equity: Granted 8,000 ESOPs under the RSU Plan (Jul 28). Trading Activity: The board trading window closed from Oct 1, reopening 48 hours post-result. Recent bulk deals show sideways positioning by Graviton Research Capital; no material insider selling at distressed levels. Assessment: No operational red flags; governance events are routine. The Somit USA liquidation is post-acquisition cleanup and does not affect core operations.
Bottom Line
KPIT's Q2 FY-2027 result on Oct 28 will be a stabilization test. Management has promised Q2 revenue in the 'similar range' to Q1 (₹1,675 Cr, flat YoY in USD), a deliberate de-escalation of expectations after Q1's 1% YoY USD decline from OEM shocks. The key swing factors are twofold: (1) margin recovery—whether operating profit rebounds from Q1's compressed levels as revenue stabilizes, and (2) order execution—whether the TCV pipeline (₹257M won in Q1) translates into visible ramp and offsets ongoing client churn. The stock is down 72% from all-time high and trades below both 50-day and 200-day moving averages, leaving room for relief if Q2 and H2 outlook steady. Watch for clarity on European OEM stabilization, India-focused growth drivers, and management's revised full-year trajectory.
Three things to watch on result day: (1) Q2 revenue level vs. Q1 and guidance range—any misses will reignite OEM headwind fears. (2) EBITDA margin and management commentary on cost structure post-client actions. (3) Updated H2 outlook: does management maintain full-year growth targets, or revise lower given the reshaped client base?
Informational and educational content only. Not investment advice.